Asadorian Raffi

Avg. Two Year Performance

(40%) Avg. Purchase Return
(18%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return21%(2%)(6%)(7%)(40%)
Purchase Success Rate4 of 62 of 63 of 62 of 60 of 6
Average Sale Return----------
Sale Success Rate----------
Drugs » Biotechnology

Chief Financial Officer:

Holdings: 241.65K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Drug Manufacturers - Major

Chief Financial Officer:

Holdings: 37.73K shares

Sentiment

Insider Trading Sentiment: Accumulate

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--